Forecast: Healthcare Expenditure on Over-The-Counter Medicines in Germany

Germany's healthcare expenditure on over-the-counter (OTC) medicines is poised for growth from 2024 to 2028, with forecasts indicating an increase from 8.43 billion Euros to 9.79 billion Euros. Compared to 2023, when the expenditure was lower, these projections highlight a consistent expanding trend in the OTC segment.

Year-on-year growth rates reveal an annual increase of around 4% during this period. Over the five years, the compound annual growth rate (CAGR) suggests approximately 3.8% expansion per annum. This indicates steady consumer reliance on OTC products, possibly due to an aging population and rising healthcare awareness.

Future Trends to Watch:

• Innovations in digital health solutions influencing OTC purchases.
• E-commerce channels reshaping consumer buying habits.
• Impact of regulatory changes on market dynamics.